查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701875

止血劑和組織密封劑市場報告（按產品類型、材料類型（膠原蛋白基、氧化再生纖維素基、明膠基、多醣基及其他）、應用、最終用戶和地區分類）2025 年至 2033 年

Hemostasis and Tissue Sealing Agents Market Report by Product Type, Material Type (Collagen-based, Oxidized Regenerated Cellulose based, Gelatin-based, Polysaccharide-based, and Others), Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球止血和組織封閉劑市場規模達 73 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 125 億美元，2025-2033 年期間的成長率 (CAGR) 為 5.89%。由於外科手術數量的增加、技術進步導致產品功效、安全性和易用性的提高，以及心血管疾病、癌症和糖尿病等慢性疾病的盛行率不斷上升，市場正在經歷穩定成長。

止血與組織密封劑市場分析：

市場成長與規模：由於對微創（MI）手術的偏好不斷增加，以及有利的管理舉措，市場正在經歷適度成長。

技術進步：先進的生物材料、輸送系統和改進的止血性能正在推動市場成長。

產業應用：止血劑和組織密封劑廣泛應用於各種外科手術，包括心血管和骨科。

地理趨勢：北美引領市場，得益於其高度發展的醫療保健基礎設施、先進的醫療技術和熟練的醫療保健專業人員。然而，由於醫療保健基礎設施的改善，亞太地區正在成為一個快速成長的市場。

競爭格局：主要參與者正在投資研發 (R&D) 活動，以探索新型生物材料、配方和輸送系統，從而提高產品的功效、安全性和可用性。

挑戰與機會：雖然市場面臨產品安全問題等挑戰，但由於人們越來越重視解決未滿足的醫療需求，市場也遇到了機會。

未來展望：隨著老年人口的增加，止血和組織密封劑市場的未來前景看好。此外，對成本效益和基於價值的護理的需求不斷成長預計將促進市場成長。

止血和組織密封劑市場趨勢：

外科手術數量不斷增加

全球範圍內外科手術數量的不斷增加，推動了止血和組織密封劑市場的成長。人們患有各種需要手術介入的疾病。止血劑和組織密封劑對於從常規手術到複雜手術的各種外科手術過程中控制出血和促進癒合至關重要。此外，對有效止血和密封解決方案的需求不斷成長，以解決出血併發症並改善患者預後，正在推動市場成長。複雜的手術通常涉及複雜的組織解剖和操作，導致更高的出血併發症風險。止血劑和組織密封劑在解決這些挑戰和確保成功結果方面發揮關鍵作用。此外，人們對腹腔鏡和機器人輔助手術等心肌梗塞手術技術的日益青睞也促進了市場的成長。雖然心肌梗塞手術具有創傷小、恢復快等優點，但仍需要有效的止血控制和組織封閉，而這需要專門的產品來實現。

技術進步

止血和組織密封劑的技術創新有助於提高產品的功效、安全性和易用性。這些進步包括新型生物材料、先進輸送系統和改進的止血性能的開發。此外，引入具有優越凝血機制的止血劑和具有增強黏合性的組織密封劑，可以更好地止血和傷口閉合。生物相容性材料和可生物分解配方的進步解決了組織相容性和長期安全性方面的擔憂。此外，新穎的輸送系統能夠將止血劑和組織密封劑精確地應用於手術部位。這些系統包括噴霧器、注射劑型或允許控制和有針對性地輸送藥劑的專用裝置。標靶輸送系統可提高手術效率、減少浪費並增強止血和組織封閉劑的有效性。除此之外，可生物分解的止血劑和組織密封劑會隨著時間的推移而分解並被人體吸收，因此無需隨後進行移除或干涉。

慢性病盛行率不斷上升

心血管疾病、癌症和糖尿病等慢性疾病的日益流行，正在刺激對止血劑和組織密封劑的需求。慢性病通常需要手術診斷、治療或管理。由於生活方式、環境因素和飲食習慣的改變，人們患這些疾病的幾率越來越大。慢性傷口，例如糖尿病潰瘍、壓瘡和靜脈潰瘍，是慢性疾病的常見併發症，通常需要手術介入進行清創、閉合或處理。這些手術中使用止血劑和組織密封劑來促進止血、促進傷口閉合和加速癒合。除此之外，患有慢性疾病的患者可能會出現合併症或生理障礙，這會增加手術併發症的風險，包括出血和傷口癒合問題。止血和組織密封劑透過控制出血、密封組織和促進最佳傷口癒合在減輕這些風險方面發揮關鍵作用，從而支持了市場的成長。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球止血與組織密封劑市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品類型

  • 外用止血劑
  • 黏合劑和組織密封劑

第7章：市場區隔：依材料類型

  • 膠原蛋白基
  • 基於氧化再生纖維素（ORC）
  • 明膠基
  • 多醣基
  • 其他

第 8 章：市場區隔：按應用

  • 一般外科
  • 微創手術
  • 其他

第9章：市場區隔：依最終用戶

  • 醫院
  • 門診手術中心
  • 居家照護環境
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Advance Medical Solution Group Plc.
    • Artivion Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton, Dickinson & Company
    • Integra LifeSciences Corporation
    • Johnson & Johnson
    • Medtronic plc
    • Pfizer Inc.
    • Smith & Nephew plc
    • Terumo Corporation
Product Code: SR112025A6397

The global hemostasis and tissue sealing agents market size reached USD 7.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.89% during 2025-2033. The market is experiencing steady growth driven by rising number of surgical procedures, technological advancements leading to enhanced product efficacy, safety, and ease of use, and increasing prevalence of chronic diseases, such as cardiovascular ailments, cancer, and diabetes.

Hemostasis and Tissue Sealing Agents Market Analysis:

Market Growth and Size: The market is witnessing moderate growth on account of increasing preferences for minimally invasive (MI) surgeries, along with favorable governing initiatives.

Technological Advancements: Advanced biomaterials, delivery systems, and improved hemostatic properties are propelling the market growth.

Industry Applications: Hemostasis and tissue sealing agents find applications across a wide range of surgical procedures, including cardiovascular and orthopedic.

Geographical Trends: North America leads the market, driven by the presence of highly developed healthcare infrastructure with access to advanced medical technologies and skilled healthcare professionals. However, Asia Pacific is emerging as a fast-growing market due to the improving healthcare infrastructure.

Competitive Landscape: Key players are investing in research and development (R&D) activities to explore novel biomaterials, formulations, and delivery systems for enhancing product efficacy, safety, and usability.

Challenges and Opportunities: While the market faces challenges, such as product safety concerns, it also encounters opportunities on account of the rising focus on addressing unmet medical needs.

Future Outlook: The future of the hemostasis and tissue sealing agents market looks promising with the increasing geriatric population. In addition, the rising need for cost-effectiveness and value-based care is anticipated to bolster the market growth.

Hemostasis and Tissue Sealing Agents Market Trends:

Rising number of surgical procedures

The increasing number of surgical procedures among the masses across the globe is supporting the hemostasis and tissue sealing agents market growth. People are suffering from various diseases that require surgical intervention. Hemostasis and tissue sealing agents are vital for controlling bleeding and promoting healing during various surgical interventions, ranging from routine procedures to complex surgeries. Additionally, the rising need for effective hemostatic and sealing solutions to address bleeding complications and enhance patient outcomes is propelling the market growth. Complex surgeries often involve intricate tissue dissection and manipulation, leading to a higher risk of bleeding complications. Hemostasis and tissue sealing agents play a critical role in addressing these challenges and ensuring successful outcomes. Furthermore, increasing preferences for MI surgical techniques, such as laparoscopic and robotic-assisted procedures, are contributing to the market growth. While MI surgeries offer benefits like reduced trauma and faster recovery times, they still require effective hemostatic control and tissue sealing, which are facilitated by specialized products.

Technological Advancements

Technological innovations in hemostasis and tissue sealing agents assist in enhancing product efficacy, safety, and ease of use. These advancements include the development of novel biomaterials, advanced delivery systems, and improved hemostatic properties. Moreover, the introduction of hemostatic agents with superior clotting mechanisms and tissue sealants with enhanced adhesive properties enable better hemostasis and wound closure. Advancements in biocompatible materials and biodegradable formulations address concerns regarding tissue compatibility and long-term safety. Furthermore, novel delivery systems enable the precise application of hemostasis and tissue sealing agents to the surgical site. These systems include spray applicators, injectable formulations, or specialized devices that allow for controlled and targeted delivery of the agents. Targeted delivery systems improve surgical efficiency, minimize wastage, and enhance the effectiveness of hemostasis and tissue sealing agents. Besides this, biodegradable hemostasis and tissue sealing agents are designed to degrade over time and be absorbed by the body, eliminating the need for subsequent removal or intervention.

Increasing prevalence of chronic diseases

The growing prevalence of chronic diseases, such as cardiovascular ailments, cancer, and diabetes, is catalyzing demand for hemostasis and tissue sealing agents. Chronic conditions often require surgical procedures for diagnosis, treatment, or management. People are increasingly suffering from these diseases due to changing lifestyles, environmental factors, and eating habits. Chronic wounds, such as diabetic ulcers, pressure ulcers, and venous ulcers, are common complications of chronic diseases and often require surgical intervention for debridement, closure, or management. Hemostasis and tissue sealing agents are utilized in these procedures to promote hemostasis, facilitate wound closure, and accelerate healing. Apart from this, patients with chronic diseases may present with comorbidities or physiological impairments that increase the risk of surgical complications, including bleeding and wound healing issues. Hemostasis and tissue sealing agents play a critical role in mitigating these risks by controlling bleeding, sealing tissues, and promoting optimal wound healing, which is supporting the market growth.

Hemostasis and Tissue Sealing Agents Industry Segmentation:

Breakup by Product Type:

  • Topical Hemostats
  • Adhesive and Tissue Sealant

Topical hemostats account for the majority of the market share

Topical hemostats are agents applied directly to the bleeding site to control bleeding. They are available in various forms, such as powders, gels, sponges, and patches. These hemostats work by promoting coagulation, accelerating clot formation, or enhancing platelet aggregation to achieve hemostasis. They are particularly useful in surgical procedures where direct pressure or conventional methods may not be sufficient to achieve hemostasis.

Adhesive and tissue sealant products are used to seal tissues, close wounds, or bond tissues together. They are available in liquid, gel, or film forms and are applied directly to the tissue surface. These products contain biocompatible materials that adhere to the tissue surface and create a barrier, promoting wound healing and preventing leakage or further bleeding.

Breakup by Material Type:

  • Collagen-based
  • Oxidized Regenerated Cellulose (ORC) based
  • Gelatin-based
  • Polysaccharide-based
  • Others

Collagen-based hemostats utilize collagen, a protein found in connective tissues. Collagen promotes platelet adhesion and activation, initiating the clotting cascade to achieve hemostasis. Collagen-based hemostats are available in various forms, such as sponges, powders, or patches, and are widely used in surgical procedures across different specialties.

Oxidized regenerated cellulose (ORC) based hemostats are derived from cellulose, a polysaccharide found in plants. Through a process of oxidation and regeneration, cellulose is converted into ORC, which possesses hemostatic properties. ORC-based hemostats work by promoting platelet aggregation and accelerating clot formation at the bleeding site. They are available in different forms like gauzes, pads, or powders and are commonly used in surgeries where rapid hemostasis is required.

Gelatin-based hemostats are derived from collagen obtained from animal sources, usually bovine or porcine. Gelatin possesses hemostatic properties and is often combined with thrombin or other clotting factors to enhance its efficacy. These hemostats come in various forms, such as sponges, powders, or sheets, and are used in surgical procedures to control bleeding and promote wound healing.

Polysaccharide-based hemostats utilize polysaccharides, complex carbohydrates found in plants or animals. These hemostats work by promoting platelet activation and aggregation, facilitating clot formation. Polysaccharide-based hemostats include products derived from substances like chitosan, alginate, or starch. They are available in different forms like powders, gels, or films and are utilized in surgical procedures to achieve hemostasis and promote tissue sealing.

Breakup by Application:

  • General Surgery
  • Minimally Invasive Surgery
  • Others

General surgery represents the leading market segment

General surgery encompasses a wide range of surgical procedures involving various organs and tissues within the body. These surgeries can include procedures, such as appendectomies, hernia repairs, gallbladder removals, and bowel surgeries. Hemostasis and tissue sealing agents play a crucial role in general surgery by controlling bleeding, sealing tissues, and promoting wound healing. These agents are used to manage bleeding from incisions, dissected tissues, and damaged vessels, ensuring optimal surgical outcomes and patient recovery.

Minimally invasive surgery (MIS), also known as laparoscopic or keyhole surgery, involves performing surgical procedures through small incisions using specialized instruments and a camera for visualization. MIS offers several advantages as compared to traditional open surgery, such as reduced post-operative pain, shorter hospital stays, and quicker recovery times. In minimally invasive (MI) procedures, hemostasis and tissue sealing agents are essential for controlling bleeding and sealing tissues through small incisions. These agents are applied directly to the surgical site to achieve hemostasis and ensure optimal tissue closure.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others

Hospitals serve as primary settings for a wide range of medical interventions, including surgical procedures requiring hemostasis and tissue sealing agents. These facilities encompass various departments, such as operating rooms, emergency departments, and specialty units, where surgeries are performed. Hospitals have comprehensive resources, including specialized equipment, trained personnel, and integrated healthcare services, making them key users of hemostasis and tissue sealing agents. These agents are used across different surgical specialties within hospital settings to control bleeding, seal tissues, and promote wound healing.

Ambulatory surgical centers (ACSs), also known as outpatient surgery centers or day surgery centers, provide surgical services on an outpatient basis, allowing patients to undergo procedures without overnight hospitalization. ASCs offer a convenient and cost-effective alternative to traditional hospital-based surgeries, particularly for minor or elective procedures. In ASCs, hemostasis and tissue sealing agents are utilized to control bleeding and promote wound closure during various surgical interventions. These centers often specialize in specific surgical specialties, such as ophthalmology, orthopedics, or gastroenterology, where hemostasis and tissue sealing agents are routinely used to ensure safe and efficient surgical outcomes.

Home care settings involve the provision of medical care, including post-operative care, within the home of patients. Hemostasis and tissue sealing agents are used to address wound complications, promote healing, and prevent infections, ensuring continuity of care and facilitating the recovery process of patients within the comfort of their homes.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest hemostasis and tissue sealing agents market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share due to the presence of highly developed healthcare infrastructure, with access to advanced medical technologies and skilled healthcare professionals. Additionally, the rising number of surgical procedures among individuals is bolstering the market growth.

Asia Pacific stands as another key region in the market, driven by the increasing adoption of MI surgeries among the masses. In addition, improving healthcare infrastructure is contributing to the growth of the market.

Europe maintains a strong presence in the market, with the rising prevalence of chronic diseases among individuals. Besides this, stringent standards for the approval and marketing of medical devices, including hemostasis and tissue sealing agents, are impelling the market growth.

Latin America exhibits the growing potential in the market on account of the increasing need for hemostasis and tissue sealing agents during surgical interventions. Furthermore, the rising awareness among healthcare professionals and patients about the benefits of advanced surgical techniques and medical products is bolstering the market growth.

The Middle East and Africa region is primarily driven by improving healthcare infrastructure. Moreover, thriving medical tourism in the region is propelling the market growth.

Leading Key Players in the Hemostasis and Tissue Sealing Agents Industry:

Key players are investing in R&D activities to explore novel biomaterials, formulations, and delivery systems to enhance product efficacy, safety, and usability. They are continuously innovating their product offerings to meet the diverse needs of healthcare providers and patients by developing advanced hemostatic agents and tissue sealants with enhanced hemostatic properties, faster sealing times, and improved biocompatibility. In addition, companies are expanding the indications for their hemostasis and tissue sealing agents, making them applicable to a wider range of surgical procedures. This involves obtaining regulatory approvals for new indications and conducting clinical trials to demonstrate product efficacy and safety in different surgical specialties. Furthermore, companies are expanding their market reach by entering new geographical regions.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Advance Medical Solution Group Plc.

  • Artivion Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson & Company
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Pfizer Inc.
  • Smith & Nephew plc
  • Terumo Corporation

Key Questions Answered in This Report

  • 1.What was the size of the global hemostasis and tissue sealing agents market in 2024?
  • 2.What is the expected growth rate of the global hemostasis and tissue sealing agents market during 2025-2033?
  • 3.What are the key factors driving the global hemostasis and tissue sealing agents market?
  • 4.What has been the impact of COVID-19 on the global hemostasis and tissue sealing agents market?
  • 5.What is the breakup of the global hemostasis and tissue sealing agents market based on the product type?
  • 6.What is the breakup of the global hemostasis and tissue sealing agents market based on the application?
  • 7.What are the key regions in the global hemostasis and tissue sealing agents market?
  • 8.Who are the key players/companies in the global hemostasis and tissue sealing agents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hemostasis and Tissue Sealing Agents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Topical Hemostats
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Adhesive and Tissue Sealant
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Material Type

  • 7.1 Collagen-based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oxidized Regenerated Cellulose (ORC) based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Gelatin-based
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Polysaccharide-based
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 General Surgery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Minimally Invasive Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Home Care Settings
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Advance Medical Solution Group Plc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Artivion Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 B. Braun Melsungen AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Baxter International Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Becton, Dickinson & Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Integra LifeSciences Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Johnson & Johnson
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Medtronic plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Smith & Nephew plc
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Terumo Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Hemostasis and Tissue Sealing Agents Market: Major Drivers and Challenges
  • Figure 2: Global: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Material Type (in %), 2024
  • Figure 6: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Hemostasis and Tissue Sealing Agents Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Hemostasis and Tissue Sealing Agents (Topical Hemostats) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Hemostasis and Tissue Sealing Agents (Topical Hemostats) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Hemostasis and Tissue Sealing Agents (Adhesive and Tissue Sealant) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Hemostasis and Tissue Sealing Agents (Adhesive and Tissue Sealant) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Hemostasis and Tissue Sealing Agents (Collagen-based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Hemostasis and Tissue Sealing Agents (Collagen-based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Hemostasis and Tissue Sealing Agents (Oxidized Regenerated Cellulose (ORC) based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Hemostasis and Tissue Sealing Agents (Oxidized Regenerated Cellulose (ORC) based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Hemostasis and Tissue Sealing Agents (Gelatin-based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Hemostasis and Tissue Sealing Agents (Gelatin-based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Hemostasis and Tissue Sealing Agents (Polysaccharide-based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Hemostasis and Tissue Sealing Agents (Polysaccharide-based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Hemostasis and Tissue Sealing Agents (Other Material Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Hemostasis and Tissue Sealing Agents (Other Material Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Hemostasis and Tissue Sealing Agents (General Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Hemostasis and Tissue Sealing Agents (General Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Hemostasis and Tissue Sealing Agents (Minimally Invasive Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Hemostasis and Tissue Sealing Agents (Minimally Invasive Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Hemostasis and Tissue Sealing Agents (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Hemostasis and Tissue Sealing Agents (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Hemostasis and Tissue Sealing Agents (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Hemostasis and Tissue Sealing Agents (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Hemostasis and Tissue Sealing Agents (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Hemostasis and Tissue Sealing Agents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Hemostasis and Tissue Sealing Agents (Home Care Settings) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Hemostasis and Tissue Sealing Agents (Home Care Settings) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Hemostasis and Tissue Sealing Agents (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Hemostasis and Tissue Sealing Agents (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Hemostasis and Tissue Sealing Agents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Hemostasis and Tissue Sealing Agents Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Hemostasis and Tissue Sealing Agents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Hemostasis and Tissue Sealing Agents Industry: SWOT Analysis
  • Figure 87: Global: Hemostasis and Tissue Sealing Agents Industry: Value Chain Analysis
  • Figure 88: Global: Hemostasis and Tissue Sealing Agents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hemostasis and Tissue Sealing Agents Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Breakup by Material Type (in Million USD), 2025-2033
  • Table 4: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Hemostasis and Tissue Sealing Agents Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Hemostasis and Tissue Sealing Agents Market: Competitive Structure
  • Table 8: Global: Hemostasis and Tissue Sealing Agents Market: Key Players